L Daniel Browne - Net Worth and Insider Trading
L Daniel Browne Net Worth
The estimated net worth of L Daniel Browne is at least $527,575 dollars as of 2024-05-15. L Daniel Browne is the CEO and President of Revance Therapeutics Inc and owns about 151,602 shares of Revance Therapeutics Inc (RVNC) stock worth over $527,575. Details can be seen in L Daniel Browne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that L Daniel Browne has not made any transactions after 2019-03-18 and currently still holds the listed stock(s).
Transaction Summary of L Daniel Browne
L Daniel Browne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L Daniel Browne owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of L Daniel Browne’s form 4 insider trades.
Insider Ownership Summary of L Daniel Browne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2019-03-18 | director & CEO and President |
L Daniel Browne Latest Holdings Summary
L Daniel Browne currently owns a total of 1 stock. L Daniel Browne owns 151,602 shares of Revance Therapeutics Inc (RVNC) as of March 18, 2019, with a value of $527,575.
Latest Holdings of L Daniel Browne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2019-03-18 | 151,602 | 3.48 | 527,575 |
Holding Weightings of L Daniel Browne
L Daniel Browne Form 4 Trading Tracker
According to the SEC Form 4 filings, L Daniel Browne has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 11,613 shares on March 18, 2019, which brought L Daniel Browne around $180,118.
Insider Trading History of L Daniel Browne
- 1
L Daniel Browne Trading Performance
L Daniel Browne Ownership Network
L Daniel Browne Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
L Daniel Browne is the director & CEO and President of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, L Daniel Browne made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 68,485 shares made by Tobin Schilke , a net sale of 194,674 shares made by Mark J Foley , and a net sale of 82,875 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 29,089 shares of Revance Therapeutics Inc (RVNC) in total and bought 30,000 shares, with a net purchase of 911 shares. During the past 18 months, 437,660 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 407,660 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
L Daniel Browne Mailing Address
Above is the net worth, insider trading, and ownership report for L Daniel Browne. You might contact L Daniel Browne via mailing address: 7555 Gateway Boulevard, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
